Skip to main content

Decision Support

By Mike Miliard | 03:49 pm | September 15, 2016
Money from MACRA, the first direct investment in health center IT since the days of HITECH, will go toward value-based care, data exchange, clinical decision support, patient engagement, and more.
By Jessica Davis | 01:14 pm | September 12, 2016
The technology leverages the company’s 175 million patient-record years and a patient’s medical history to predict the patient’s future health.
By Mike Miliard | 12:09 pm | September 12, 2016
Roanoke, Virginia-based Carilion Clinic will put predictive analytics technology from PeraHealth to work spotting hospital patients who might be at risk.
By Mike Miliard | 02:06 pm | September 02, 2016
Fewer than one-third of healthcare providers polled for the newest HIMSS Analytics Essentials Brief are currently pursuing precision medicine initiatives – with the majority who don't saying that limitations in funding, technology or expertise are holding them back. But that's poised to change very soon.
By Bill Siwicki | 04:13 pm | August 31, 2016
The artificial intelligence subsidiary launched a new research partnership to reduce the amount of time it takes to plan radiotherapy treatment for certain cancers.
By Mike Miliard | 11:53 am | August 19, 2016
Stanford clinicians shine a light on how today's products are missing out on big opportunities.
By Bernie Monegain | 10:40 am | August 04, 2016
The company also said its scientists are working with Icahn School of Medicine at Mount Sinai to test the technology on prostate cancer.
By Jack McCarthy | 11:40 am | August 01, 2016
The entities are building a statewide health information network that will enable doctors to share real-time patient data and analytics. 
By Kaiser Health News | 12:01 pm | July 21, 2016
Researchers in California regularly use a database to search for trends, confirm potential cancer clusters and identify disparities in screening and outcomes.
By Bernie Monegain | 11:40 am | July 21, 2016
Scientists at Weill Cornell Medicine say the new genome sequencing test to detect mutations can guide precision cancer treatment with more than 95 percent accuracy.